[1]
“Efficacy Levels of Recombinant Tetravalent Dengue Vaccine (Cyd-Tdv) in Children Aged 2-16 Years: Meta-Analysis”, JISIP, vol. 8, no. 3, pp. 1583–1591, Jun. 2024, doi: 10.58258/jisip.v8i3.6988.